Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.46
-0.24 (-2.76%)
Apr 29, 2026, 12:21 PM EDT - Market open

Kyverna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
512537161---
Market Cap Growth
533.68%232.60%----
Enterprise Value
267371-151---
Last Close Price
8.709.403.74---
PB Ratio
2.262.310.61---
P/TBV Ratio
2.232.310.61---
Debt / Equity Ratio
0.130.130.030.190.230.09
Net Debt / Equity Ratio
-1.08-1.08-1.04-0.99-0.87-1.13
Net Debt / EBITDA Ratio
1.491.491.980.801.432.74
Net Debt / FCF Ratio
1.631.632.380.911.113.01
Asset Turnover
----0.09-
Quick Ratio
7.657.658.472.904.294.78
Current Ratio
7.767.768.613.064.464.84
Return on Equity (ROE)
-64.67%-64.67%-80.74%-125.95%-52.95%-
Return on Assets (ROA)
-35.47%-35.47%-46.93%-54.89%-24.10%-
Return on Capital Employed (ROCE)
-66.00%-66.00%-52.60%-112.80%-53.50%-37.90%
Earnings Yield
-31.20%-30.04%-78.95%---
FCF Yield
-29.74%-28.62%-72.13%---
Buyback Yield / Dilution
-15.46%-15.46%-5590.81%-47.89%-71.30%-
Source: S&P Capital IQ. Standard template. Financial Sources.